Pharmaxis finalises sale of MBU to Arna Pharma; shifts focus to blood-related cancer treatments
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has completed the sale of its mannitol respiratory business (MBU) to Arna Pharma Pty Ltd. On October 3, 2023, PXS...
Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has completed the sale of its mannitol respiratory business (MBU) to Arna Pharma Pty Ltd. On October 3, 2023, PXS...
ASX Futures are pointing to a strong slide in early trading today, with the ASX likely to fall 83 points or 1.2%, following tumbling US and European markets...
Australia’s benchmark index ended the session down 1.5% as local investors followed Wall Street's lead overnight on worries about rising Middle East...
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company is set to undergo a restructure to refocus on developing drugs to treat...
The ASX 200 slid to six month lows today, down 1.34% at 6,939 just before market close with all sectors ending lower except Health Care. Energy stocks were...